CoChat

Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe/PS1dE9 transgenic mice

Open access
Xu, Guilian, Green, Cameron C, Fromholt, Susan E, Borchelt, David R · 2012 · Alzheimer's Research & Therapy
Cited by 22

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Introduction: The low-density lipoprotein receptor-related protein (LRP1) and its family members have been implicated in the pathogenesis of Alzheimer's disease. Multiple susceptibility factors converge to metabolic pathways that involve LRP1, including modulation of the processing of amyloid precursor protein (APP) and the clearance of Aβ peptide. Methods: We used the Cre-lox system to lower LRP1 levels in hippocampal neurons of mice that develop Alzheimer-type amyloid by crosses between mice that express Cre recombinase under the transcriptional control of the GFAP promoter, mice that harbor loxp sites in the LRP1 gene, and the APPswe/PS1dE9 transgenic model. We compared amyloid plaque numbers in APPswe/PS1dE9 mice lacking LRP1 expression in hippocampus (n = 13) to mice with normal levels of LRP1 (n = 12). Student t-test was used to test whether there were significant differences in plaque numbers and amyloid levels between the groups. A regression model was used to fit two regression lines for these groups, and to compare the rates of Aβ accumulation. Results: Immunohistochemical analyses demonstrated efficient elimination of LRP1 expression in the CA fields and dentate gyrus of the hippocampus. Within hippocampus, we observed no effect on the severity of amyloid deposition, the rate of Aβ40/42 accumulation, or the architecture of amyloid plaques when LRP1 levels were reduced. Conclusions: Expression of LRP1 by neurons in proximity to senile amyloid plaques does not appear to play a major role in modulating the formation of these proximal deposits or in the appearance of the associated neuritic pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/alzrt110

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Andersen OM, Willnow TE: Lipoprotein receptors in Alzheimer's disease. Trends Neurosci. 2006, 29: 687-694. 10.1016/j.tins.2006.09.002. · DOI · Paper page
  2. Bu G, Maksymovitch EA, Nerbonne JM, Schwartz AL: Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem. 1994, 269: 18521-18528. · DOI · Paper page
  3. Rebeck GW, Harr SD, Strickland DK, Hyman BT: Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol. 1995, 37: 211-217. 10.1002/ana.410370212. · DOI · Paper page
  4. Marzolo MP, von Bernhardi R, Bu G, Inestrosa NC: Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J Neurosci Res. 2000, 60: 401-411. 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L. · DOI · Paper page
  5. Rebeck GW, Moir RD, Mui S, Strickland DK, Tanzi RE, Hyman BT: Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP. Brain Res Mol Brain Res. 2001, 87: 238-245. · DOI · Paper page
  6. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994, 13: 45-53. 10.1016/0896-6273(94)90458-8. · DOI · Paper page
  7. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH: FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci. 2004, 24: 4259-4265. 10.1523/JNEUROSCI.5451-03.2004. · DOI · Paper page
  8. Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-Demotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA: Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis. 2009, 17: 553-570. · DOI · Paper page
  9. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R: Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 1997, 49: 56-61. 10.1212/WNL.49.1.56. · DOI · Paper page
  10. Van Uden E, Kang DE, Koo EH, Masliah E: LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis. Microsc Res Tech. 2000, 50: 268-272. 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1. · DOI · Paper page
  11. Qiu Z, Strickland DK, Hyman BT, Rebeck GW: Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem. 1999, 73: 1393-1398. · DOI · Paper page
  12. Herz J, Strickland DK: LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 2001, 108: 779-784. · DOI · Paper page
  13. Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT: Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol. 2000, 47: 739-747. 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8. · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
  14. Herz J, Clouthier DE, Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 1992, 71: 411-421. 10.1016/0092-8674(92)90511-A. · DOI · Paper page
  15. Willnow TE, Armstrong SA, Hammer RE, Herz J: Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci USA. 1995, 92: 4537-4541. 10.1073/pnas.92.10.4537. · DOI · Paper page
  16. Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, Messing A: hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis. 2001, 31: 85-94. 10.1002/gene.10008. · DOI · Paper page
  17. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP: Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 2002, 418: 422-425. 10.1038/nature00838. · DOI · Paper page
  18. Rohlmann A, Gotthardt M, Willnow TE, Hammer RE, Herz J: Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat Biotechnol. 1996, 14: 1562-1565. 10.1038/nbt1196-1562. · DOI
  19. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR: Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001, 17: 157-165. 10.1016/S1389-0344(01)00067-3. · DOI · Paper page
  20. Lesuisse C, Xu G, Anderson J, Wong M, Jankowsky J, Holtz G, Gonzalez V, Wong PC, Price DL, Tang F, Wagner S, Borchelt DR: Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet. 2001, 10: 2525-2537. 10.1093/hmg/10.22.2525. · DOI · Paper page
  21. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH, Price DL, Sisodia SS, Cleveland DW: Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA. 1994, 91: 8292-8296. 10.1073/pnas.91.17.8292. · DOI · Paper page
  22. Guntern R, Bouras C, Hof PR, Vallet PG: An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia. 1992, 48: 8-10. 10.1007/BF01923594. · DOI
  23. Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L, Borchelt DR: Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet. 2011, 20: 2770-2782. 10.1093/hmg/ddr176. · DOI
  24. Hirano A, Zimmerman HM: Silver impregnation of nerve cells and fibers in celloidin sections. A simple impregnation technique. Arch Neurol. 1962, 6: 114-122. 10.1001/archneur.1962.00450200028003. · DOI
  25. Yamamoto T, Hirano A: A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol. 1986, 12: 3-9. 10.1111/j.1365-2990.1986.tb00677.x. · DOI · Paper page
  26. Bu G, Geuze HJ, Strous GJ, Schwartz AL: 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. Embo J. 1995, 14: 2269-80. · DOI · Paper page

Cited by

See all 22

Metadata

Authors
Xu, G., Green, C. C., Fromholt, S. E., & Borchelt, D. R.
Venue
Alzheimer's Research & Therapy
Published
2012-04-26
Volume
4
Issue
2
Pages
12-12
ISSN
1758-9193 (ISSN-L)
OpenAlex
W2001328100
Cited by
22
References
12
FWCI
1.70
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.